Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Design · Health
Size
51-200 employees
Stage
Series B
founded in
2021
Aera Therapeutics is a biotechnology company focused on harnessing the power of genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that package and transfer nucleic acid cargo, addressing the limitations of current delivery technologies. Aera aims to expand the reach of genetic medicines across various therapeutic areas, thereby benefiting a broader patient population. The company is led by a distinguished team of industry leaders and scientists, positioning itself as a key player in the genetic medicine landscape.
Something looks off?